IDX102 is the active metabolite of IDX184—i.e. the monophosphate nucleotide that the IDX184 prodrug resolves to in vivo. (IDX102 looks like the right-hand diagram in #msg-42396728.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”